Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions - Additional Information (Detail)

v3.7.0.1
Related Party Transactions - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
May 10, 2017
Jun. 27, 2016
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Related Party Transaction [Line Items]              
Cash received from sale of business           $ 1,250,000  
Intrexon [Member]              
Related Party Transaction [Line Items]              
Accounts payable and accrued expenses     $ 615,168   $ 615,168   $ 524,620
Intrexon [Member] | Exclusive Channel Collaboration Agreements [Member]              
Related Party Transaction [Line Items]              
Cash paid to Intrexon Corporation     $ 0 $ 500,770 $ 524,620 $ 933,375  
Unsecured Non-convertible Promissory Note [Member] | Intrexon [Member]              
Related Party Transaction [Line Items]              
Debt instrument, face amount $ 2,400,000            
Debt instrument, term 2 years            
Interest rate 12.00%            
Intrexon [Member] | Principal Owner [Member]              
Related Party Transaction [Line Items]              
Percentage of outstanding common stock     31.40% 31.50% 31.40% 31.50%  
Discontinued Operations Disposed of by Sale [Member] | ProBiora Health, LLC [Member]              
Related Party Transaction [Line Items]              
Interest rate   1.00%          
Sales price of business   $ 1,700,000          
Cash received from sale of business   1,250,000          
Receivable from sale of business   $ 450,000          
Contingent consideration payment period   10 years          
Buyer revenue threshold for contingent consideration   $ 2,000,000          
Discontinued Operations Disposed of by Sale [Member] | Maximum [Member] | ProBiora Health, LLC [Member]              
Related Party Transaction [Line Items]              
Contingent consideration   $ 2,000,000